mpMRI should be performed in patients with prior negative biopsies if clinical suspicion remains |
Online |
mpMRI should not be performed as stand-alone diagnostic tool or with mpMRI-targeted biopsies only |
Online |
mpMRI should be performed following standard biopsy-based PCa diagnosis in both the planning and follow-up of FT |
Online |
MRI-TRUS fusion is the recommended technique to perform biopsies following mpMRI |
Online |
Systematic biopsies are still required for FT planning in biopsy-naïve patients and patients with residual PCa after FT |
Online |
Repeat biopsies should be taken during the follow-up of FT |
Online |
The final decision to perform FT should be based on histopathology and not be based on mpMRI results alone |
Online |
Only in expert centers, where the quality is assured and own results are monitored, mpMRI may be performed in all patients suspected of PCa |
Panel |
Only in expert centers, deferral of repeat biopsy may be considered in case of a negative mpMRI |
Panel |
It should be our goal to guarantee high-quality mpMRI throughout the urological community before implementing it as standard of care |
Panel |